Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.

White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC.

JACC Cardiovasc Imaging. 2013 Sep;6(9):955-62. doi: 10.1016/j.jcmg.2013.01.011. Epub 2013 Apr 10.

2.

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.

Fontana M, White SK, Banypersad SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N, Moon JC.

J Cardiovasc Magn Reson. 2012 Dec 28;14:88. doi: 10.1186/1532-429X-14-88.

3.

Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.

Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M.

Circ Cardiovasc Imaging. 2013 May 1;6(3):373-83. doi: 10.1161/CIRCIMAGING.112.000192. Epub 2013 Apr 3.

4.

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY.

Circ Cardiovasc Imaging. 2013 May 1;6(3):415-22. doi: 10.1161/CIRCIMAGING.112.000333. Epub 2013 Apr 2.

5.

Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus.

Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, Shroff SG, Wong TC.

J Cardiovasc Magn Reson. 2011 Mar 4;13:16. doi: 10.1186/1532-429X-13-16.

6.

Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.

Neilan TG, Coelho-Filho OR, Shah RV, Abbasi SA, Heydari B, Watanabe E, Chen Y, Mandry D, Pierre-Mongeon F, Blankstein R, Kwong RY, Jerosch-Herold M.

JACC Cardiovasc Imaging. 2013 Jun;6(6):672-83. doi: 10.1016/j.jcmg.2012.09.020. Epub 2013 May 1.

7.

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 Apr 28;14:26. doi: 10.1186/1532-429X-14-26.

8.

Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.

Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, O h-Ici D, Klein C, Berger F, Kuehne T.

Circ Cardiovasc Imaging. 2011 Nov;4(6):636-40. doi: 10.1161/CIRCIMAGING.111.966796. Epub 2011 Sep 14.

9.

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H.

Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):210-6. doi: 10.1093/ehjci/jeu183. Epub 2014 Sep 22.

10.

Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance.

Hwang SH, Choi EY, Park CH, Paek MY, Greiser A, Kim TH, Choi BW.

Int J Cardiovasc Imaging. 2014 Dec;30 Suppl 2:137-44. doi: 10.1007/s10554-014-0489-6. Epub 2014 Jul 15.

PMID:
25022430
11.

Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).

Liu CY, Liu YC, Wu C, Armstrong A, Volpe GJ, van der Geest RJ, Liu Y, Hundley WG, Gomes AS, Liu S, Nacif M, Bluemke DA, Lima JA.

J Am Coll Cardiol. 2013 Oct 1;62(14):1280-7. doi: 10.1016/j.jacc.2013.05.078. Epub 2013 Jul 17.

12.

Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.

Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY.

JACC Cardiovasc Imaging. 2012 Sep;5(9):897-907. doi: 10.1016/j.jcmg.2012.04.006.

13.

T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 May 1;14:27. doi: 10.1186/1532-429X-14-27.

14.

Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.

Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE.

J Cardiovasc Magn Reson. 2012 Sep 11;14:64. doi: 10.1186/1532-429X-14-64.

15.

Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla.

McDiarmid AK, Swoboda PP, Erhayiem B, Ripley DP, Kidambi A, Broadbent DA, Higgins DM, Greenwood JP, Plein S.

J Cardiovasc Magn Reson. 2015 Jan 31;17(1):6. doi: 10.1186/s12968-015-0112-6.

16.

Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.

Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A.

Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1004-12. doi: 10.1093/ehjci/jeu050. Epub 2014 Mar 30.

17.

Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.

Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, Cox AT, Fontana M, Whelan CJ, Wechalekar AD, Hawkins PN, Moon JC.

Circ Cardiovasc Imaging. 2013 Jan 1;6(1):34-9. doi: 10.1161/CIRCIMAGING.112.978627. Epub 2012 Nov 28.

18.

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.

Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S.

JACC Cardiovasc Imaging. 2013 Oct;6(10):1048-58. doi: 10.1016/j.jcmg.2013.03.008. Epub 2013 Sep 4.

19.

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.

Brouwer WP, Baars EN, Germans T, de Boer K, Beek AM, van der Velden J, van Rossum AC, Hofman MB.

J Cardiovasc Magn Reson. 2014 Apr 25;16:28. doi: 10.1186/1532-429X-16-28.

20.

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC.

Circulation. 2010 Jul 13;122(2):138-44. doi: 10.1161/CIRCULATIONAHA.109.930636. Epub 2010 Jun 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk